As the delta version of the Chinese Communist Party (CCP) Virus disperses across the United States, Dr. Anthony Fauci is concerned about the gap between vaccinated and unvaccinated individuals, predicting that “two Americas” may emerge.
“When you have such a low level of vaccination superimposed upon a variant that has a high degree of efficiency of spread, what you are going to see among under-vaccinated regions, be that states, cities, or counties, you’re going to see these individual types of blips,” Fauci claimed. “It’s almost like it’s going to be two Americas.”
According to the Center for Disease Control and Prevention (CDC), the more contagious and violent delta form has spread to almost every state, accounting for 26.1% of CCP Virus cases as of Wednesday, June 1. In addition, vaccination numbers in the United States have decreased since mid-April, with the lowest coverage seen among younger individuals.
According to CDC data, more than 66% of people in the country have received at least one CCP Virus immunization, but only around 47% of the population has been fully immunized. Less than 35% of people in Mississippi, Alabama, Arkansas, Wyoming, and Louisiana are completely immunized.
Despite some municipalities, such as Los Angeles County, “strongly” advising the use of masks even for those who have been inoculated, Fauci said the CDC’s guidance would not be changed.
Fauci stated that two doses of the AstraZeneca vaccine are roughly 88% efficient against the delta version and that the Johnson & Johnson vaccine will be “just as good.”
However, according to data released by Public Health England (PHE) on Friday, June 18, the fatality rate from the Delta CCP Virus variant is six times greater among individuals who were fully vaccinated for two weeks or longer than those who never got a shot.
“This is reminiscent of the antibody dependent enhancement (ADE) phenomenon that has been seen for other vaccine, and that has been expressed as a point of concern among many scientists for the COVID vaccines,” experienced researcher Stephanie Seneff at Massachusetts Institute of Technology’s Computer Science and Artificial Intelligence Laboratory told LifeSiteNews.
The drug that all pharmaceutical companies call a ‘vaccine’ is not yet approved as such but has a controversial emergency authorization only.
The controversy is generated because this type of authorization is only granted in the presence of diseases for which there is no other alternative cure and which are causing a high number of deaths.
Thomas Massie (R-Ky.) Master of Science at MIT emphasized children and young adults are the least likely to suffer from COVID-19 and the most likely to experience myocarditis as a result of the vaccine on his Twitter account.
He added: “No one should be forced to take this vaccine. It’s especially wrong to force this vaccine on those who have recovered from the virus.”